Dipartimento per la salute della Donna e del Bambino e della Salute Pubblica, UOC Ginecologia Oncologica, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
UOC di Nutrizione Clinica, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy.
J Gynecol Oncol. 2024 Jan;35(1):e4. doi: 10.3802/jgo.2024.35.e4. Epub 2023 Sep 11.
To evaluate pre-operative predictors of early (<30 days) severe complications (grade Dindo 3+) in patients with gynecological malignancy submitted to pelvic exenteration (PE).
We retrospectively analyzed 129 patients submitted to surgery at Fondazione Policlinico Gemelli between 2010 and 2019. We included patients affected by primary or recurrent/persistent cervical, endometrial, or vulvar/vaginal cancers. Post-operative complications were graded according to the Dindo classification. Logistic regression was used to analyze potential predictors of complications.
We performed 63 anterior PE, 10 posterior PE, and 56 total PE. The incidence of early severe post-operative complications was 27.9% (n=36), and the early mortality rate was 2.3% (n=3). More frequent complications were related to the urinary diversion and intestinal surgery. In univariable analysis, hemoglobin ≤10 g/dL (odds ratio [OR]=4.2; 95% confidence interval [CI]=1.65-10.7; p=0.003), low albumin levels (OR=3.9; 95% CI=1.27-12.11; p=0.025), diabetes (OR=4.15; 95% CI=1.22-14.1; p=0.022), 2+ comorbidities at presentation (OR=5.18; 95% CI=1.49-17.93; p=0.012) were predictors of early severe complications. In multivariable analysis, only low hemoglobin and comorbidities at presentation were independent predictors of complications.
Pelvic exenteration is an aggressive surgery characterized by a high rate of post-operative complications. Pre-operative assessment of comorbidities and patient health status are crucial to better select the right candidate for this type of surgery.
评估妇科恶性肿瘤患者行盆腔廓清术(PE)后早期(<30 天)严重并发症(Dindo 分级 3+)的术前预测因素。
我们回顾性分析了 2010 年至 2019 年在 Fondazione Policlinico Gemelli 接受手术的 129 名患者。我们纳入了原发性或复发性/持续性宫颈癌、子宫内膜癌或外阴/阴道癌患者。根据 Dindo 分级系统对术后并发症进行分级。使用逻辑回归分析并发症的潜在预测因素。
我们进行了 63 例前盆腔廓清术、10 例后盆腔廓清术和 56 例全盆腔廓清术。早期严重术后并发症的发生率为 27.9%(n=36),早期死亡率为 2.3%(n=3)。更常见的并发症与尿流改道和肠道手术有关。单变量分析显示,血红蛋白≤10g/dL(比值比[OR]=4.2;95%置信区间[CI]1.65-10.7;p=0.003)、低白蛋白水平(OR=3.9;95%CI1.27-12.11;p=0.025)、糖尿病(OR=4.15;95%CI1.22-14.1;p=0.022)、就诊时存在 2+合并症(OR=5.18;95%CI1.49-17.93;p=0.012)是早期严重并发症的预测因素。多变量分析显示,只有低血红蛋白和就诊时的合并症是并发症的独立预测因素。
盆腔廓清术是一种具有高术后并发症发生率的侵袭性手术。术前评估合并症和患者健康状况对于更好地选择此类手术的合适患者至关重要。